BlackRock’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.9M | Sell |
|
|||||
|
2025
Q2 | $14M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Sell |
|
|||||
|
2024
Q4 | $11.7M | Buy |
|
|||||
|
2024
Q3 | $19.7M | Buy |
|
|||||
|
2024
Q2 | $24M | Buy |
|
|||||
|
2024
Q1 | $32.1M | Sell |
|
|||||
|
2023
Q4 | $18.2M | Sell |
|
|||||
|
2023
Q3 | $22.1M | Sell |
|
|||||
|
2023
Q2 | $79.8M | Sell |
|
|||||
|
2023
Q1 | $153M | Buy |
|
|||||
|
2022
Q4 | $175M | Buy |
|
|||||
|
2022
Q3 | $188M | Buy |
|
|||||
|
2022
Q2 | $166M | Buy |
|
|||||
|
2022
Q1 | $250M | Buy |
|
|||||
|
2021
Q4 | $260M | Sell |
|
|||||
|
2021
Q3 | $204M | Sell |
|
|||||
|
2021
Q2 | $162M | Sell |
|
|||||
|
2021
Q1 | $184M | Buy |
|
|||||
|
2020
Q4 | $143M | Buy |
|
|||||
|
2020
Q3 | $147M | Buy |
|
|||||
|
2020
Q2 | $152M | Buy |
|
|||||
|
2020
Q1 | $146M | Buy |
|
|||||
|
2019
Q4 | $174M | Buy |
|
|||||
|
2019
Q3 | $157M | Buy |
|
|||||
|
2019
Q2 | $219M | Buy |
|
|||||
|
2019
Q1 | $244M | Sell |
|
|||||
|
2018
Q4 | $182M | Sell |
|
|||||
|
2018
Q3 | $221M | Buy |
|
|||||
|
2018
Q2 | $282M | Buy |
|
|||||
|
2018
Q1 | $191M | Buy |
|
|||||
|
2017
Q4 | $138M | Buy |
|
|||||
|
2017
Q3 | $105M | Buy |
|
|||||
|
2017
Q2 | $79.1M | Sell |
|
|||||
|
2017
Q1 | $70.7M | Buy |
|
|||||
|
2016
Q4 | $287K | Buy |
|
|||||
|
2016
Q3 | $220K | Buy |
|
|||||
|
2016
Q2 | $102K | Buy |
|
|||||
|
2016
Q1 | $34K | Buy |
|
|||||
|
2015
Q4 | $12K | Hold |
|
|||||
|
2015
Q3 | $13K | Hold |
|
|||||
|
2015
Q2 | $16K | Buy |
|
|||||
|
2015
Q1 | $7K | Hold |
|
|||||
|
2014
Q4 | $12K | Hold |
|
|||||
|
2014
Q3 | $9K | Hold |
|
|||||
|
2014
Q2 | $10K | Buy |
|